Find here all the news from the CBM and beyond
1 2 3 4 7
Discover some experiences
Webinar on mRNA vaccines
Dr Dror WARSCHAWSKI,Laboratoire de Biologie Physico-Chimique des Protéines Membranaires, Paris
J.-M. Bonmatin and six co-authors have just published a letter in the January 8, 2021 issue of Science magazine, entitled "Stay true to integrated pest management"
J.-M. Bonmatin, co-author of an article in Science (December 18, 2020) questions the conclusions of a study on the decline of insects published in April
Researchers from CBM and LCC (Toulouse) have designed a new probe to detect amyloid deposits biomarkers of these diseases
The link between neoniconitoides and contamination of soils and populations highlighted
The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
The second edition, edited by Marc Boudvillain, has just been published
NMR studies show 16 metabolites discriminate symptomatic from presymptomatic stages in a Drosophila model of Huntington's disease. Potential biomarkers of the human disease?
CBM researchers in collaboration with INSERM U1195 (Kremlin-Bicêtre) have shown that the LINGO-1 receptor can form homo- and hetero-complexes with its homologs LINGO-2, LINGO-3 and LINGO-4 in the brain thus opening the way to new strategies to modulate their activity.
Researchers from CBM and the University of Michigan used a lanthanide, dysprosium, to generate pure white light with no variation in hue.